We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+13.54%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$337B
AUM Growth
+$26B
(+8.4%)
Cap. Flow
-$5.42B
Cap. Flow
% of AUM
-1.61%
Top 10 Holdings %
Top 10 Hldgs %
27.87%
Holding
3,347
New
34
Increased
1,112
Reduced
1,460
Closed
69
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Flutter Entertainment
FLUT
|
+$489M |
| 2 |
PTC
PTC
|
+$354M |
| 3 |
Citigroup
C
|
+$286M |
| 4 |
Progressive
PGR
|
+$259M |
| 5 |
Salesforce
CRM
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$574M |
| 2 |
Apple
AAPL
|
+$574M |
| 3 |
Tesla
TSLA
|
+$519M |
| 4 |
Palo Alto Networks
PANW
|
+$488M |
| 5 |
EOG Resources
EOG
|
+$333M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.2% |
| 2 | Financials | 12.48% |
| 3 | Healthcare | 11.5% |
| 4 | Consumer Discretionary | 11.02% |
| 5 | Industrials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HBI
1876
DELISTED
Hanesbrands
HBI
| $5.87M | ﹤0.01% |
1,011,966
-18,982
| -2% | -$91K |
|
1877
V2X
VVX
$2.7B
| $5.86M | ﹤0.01% |
125,507
-21,170
| -14% | -$865K |
|
|
HSII
1878
DELISTED
Heidrick & Struggles
HSII
| $5.86M | ﹤0.01% |
174,047
-2,254
| -1% | -$68.4K |
|
1879
WaFd
WAFD
$2.71B
| $5.85M | ﹤0.01% |
201,681
-161,524
| -44% | -$4.65M |
|
|
CHCT
1880
Community Healthcare Trust
CHCT
$536M
| $5.83M | ﹤0.01% |
219,521
-124,465
| -36% | -$3.28M |
|
1881
Byline Bancorp
BY
$1.78B
| $5.79M | ﹤0.01% |
266,574
+14,460
| +6% | +$311K |
|
1882
Phibro Animal Health
PAHC
$1.5B
| $5.78M | ﹤0.01% |
446,737
+176,168
| +65% | +$2.11M |
|
1883
Protolabs
PRLB
$1.7B
| $5.77M | ﹤0.01% |
161,413
-45,278
| -22% | -$1.63M |
|
1884
PAR Technology
PAR
$715M
| $5.77M | ﹤0.01% |
127,131
-45,890
| -27% | -$2.03M |
|
1885
Beam Therapeutics
BEAM
$2.68B
| $5.76M | ﹤0.01% |
174,191
-3,444
| -2% | -$107K |
|
1886
Bloom Energy
BE
$46.5B
| $5.75M | ﹤0.01% |
511,982
+2,943
| +0.6% | +$32.3K |
|
1887
Codexis
CDXS
$158M
| $5.74M | ﹤0.01% |
1,643,514
-399,559
| -20% | -$1.26M |
|
1888
Acushnet Holdings
GOLF
$6B
| $5.73M | ﹤0.01% |
86,954
-2,435
| -3% | -$158K |
|
1889
Health Catalyst
HCAT
$160M
| $5.73M | ﹤0.01% |
761,366
-11,362
| -1% | -$104K |
|
1890
Bumble
BMBL
$386M
| $5.73M | ﹤0.01% |
504,539
-4,793
| -0.9% | -$61.1K |
|
1891
Legend Biotech
LEGN
$3.65B
| $5.73M | ﹤0.01% |
102,086
-56,485
| -36% | -$3.41M |
|
|
BZUN
1892
Baozun
BZUN
$179M
| $5.72M | ﹤0.01% |
2,487,743
-376
| -0% | -$902 |
|
1893
HealthStream
HSTM
$863M
| $5.71M | ﹤0.01% |
214,178
-20,687
| -9% | -$553K |
|
1894
Tarsus Pharmaceuticals
TARS
$2.55B
| $5.7M | ﹤0.01% |
156,787
-79,655
| -34% | -$2.34M |
|
1895
Vanguard Small-Cap ETF
VB
$78.9B
| $5.7M | ﹤0.01% |
24,930
-3,300
| -12% | -$710K |
|
1896
Cohen & Steers
CNS
$4.2B
| $5.67M | ﹤0.01% |
73,794
-1,705
| -2% | -$122K |
|
|
GOGL
1897
DELISTED
Golden Ocean Group
GOGL
| $5.65M | ﹤0.01% |
439,386
| – | – |
|
1898
United Natural Foods
UNFI
$3.04B
| $5.65M | ﹤0.01% |
491,894
-94,554
| -16% | -$1.37M |
|
1899
Opendoor
OPEN
$3.54B
| $5.64M | ﹤0.01% |
1,924,204
-2,613,730
| -58% | -$8.16M |
|
1900
Travere Therapeutics
TVTX
$5.16B
| $5.64M | ﹤0.01% |
731,378
+247,050
| +51% | +$2.08M |
|
Similar funds
VFT
Nuveen's Q1 2024 Portfolio in Review
As of Q1 2024, Nuveen held 3,347 positions worth $337B, up 8.4% from $311B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.1%. Nuveen opened 34 new positions and exited 69, leaving the 3,347-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q1 2024 buy was Flutter Entertainment: 2,293,926 shares worth $458M.
- Nuveen added most to PTC in Q1 2024, an estimated $354M increase.
- Nuveen's biggest Q1 2024 reduction was Synopsys, cutting an estimated $574M.
- Nuveen fully exited Splunk Inc in Q1 2024, selling an estimated $159M.
- Nuveen's ten largest holdings make up 28% of its $337B portfolio in Q1 2024.
- Nuveen opened 34 new positions and closed 69 in Q1 2024.
- Nuveen's portfolio value rose 8.4% quarter-over-quarter to $337B.
Based on Nuveen's 13F filing for Q1 2024, filed 13 May 2024.